Tiny Gem Archives - Page 45 of 48

ThursdayJun 30, 2022 9:00 am

No Debt and a Lot of Money Sets Golden Matrix Group Inc. (NASDAQ: GMGI) Apart as It Sets Sights on ESports Too

GMGI a standout differentiated in Benzinga’s Listmakers Series: ESportsGolden Matrix will be launching a new P2P ESports betting platformGMGI is eyeing new accretive acquisitions to extend its string of nearly 4 years of consecutive profitable quarters Companies are usually willing to open their bank accounts for naming rights. For instance, FedEx is paying $7.5 million per year to have their name on the home field of the Washington Commanders. New tech brands are changing the game. In November 2021, Crypto.com agreed to pay $700 million to see the iconic Staples Center re-branded as Crypto.com Center for the next 20 years…

WednesdayJun 29, 2022 11:15 am

New Agreements Signed Between Lexaria Bioscience Corp. (NASDAQ: LEXX) and BevNology LLC; Pre-IND Meeting Request Filed with FDA

The two companies signed a manufacturing operating agreement and a commercial agreement Lexaria sent a pre-IND meeting request letter to the US FDA and plans to file the full IND application in late 2022/early 2023The FDA has acknowledged Lexaria's pre-IND request and responded with conditions prior to the target date of July 30, 2022 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has recently announced signing two agreements with BevNology LLC, the product and development arm of InterContinental Beverage Capital (“IBC”), operating its state-of-the-art lab and manufacturing facility just outside of Atlanta, Georgia. This announcement only furthers Lexaria's…

TuesdayJun 28, 2022 1:30 pm

Zacks Report Highlights Flora Growth Corp. (NASDAQ: FLGC) Aspiring to Benefit from First Mover Advantage in Multiple Cannabis Market Categories

Flora’s 2021 acquisitions allowed it to expand its operations beyond North America and into EuropeAcquisitions have also contributed to 450% YOY revenue growth for Q1 2022Its management is confident that the foundation laid down so far will yield growth for 2022 and subsequent financial yearsFlora has also reiterated 2022 revenue guidance of $35 million to $45 million 2021 was an excellent year for Flora Growth (NASDAQ: FLGC). According to a recent research report from Zacks (https://ibn.fm/xnXve), the company possesses a number of important qualities pointing to continued significant growth following a strong 2021. Flora Growth management even regarded the past…

TuesdayJun 28, 2022 12:00 pm

Mullen Automotive Inc. (NASDAQ: MULN) Retrofits Existing Facility to Move EV Battery Pack Production In-House

Global EV market projected to see 24.5% CAGR between 2022 and 2028MULN announces plans to modify high-voltage plant to produce packs used for company’s EVsCompany anticipates using its own revolutionary solid-state battery technology in its second-generation Mullen FIVE EV CrossoversStrategic move reduces company’s reliance on third-party suppliers, reduces impact of supply and critical component shortages Amid a growing global demand for electric vehicles (“EV”), smart companies operating in the space are looking for ways to differentiate themselves from the competition. That’s exactly what Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle manufacturer, has done with its recently announced plans to…

TuesdayJun 28, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Authorizes New Channel Partner to Offer AditxtScore(TM) Amid Rising COVID-19 Cases and Possible Fall/Winter Waves

Aditxt, Inc. is a is a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system. The Company’s product AditxtScore(TM) is a proprietary immune mapping technology designed to provide a personalized profile of the immune system; AditxtScore(TM) for COVID-19 is the Aditxt’s first commercial productAditxt recently announced it had authorized a new channel partner – Premier Medical Laboratory Services (“PMLS”), a leading advanced medical diagnostics lab –to offer AditxtScore(TM)This announcement comes amid reports warning of a fall and winter COVID-19 wave occasioned by waning immunity or a possible “nasty new variant”Already, the U.S. is undergoing…

MondayJun 27, 2022 2:15 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Initial Results from Feasibility Study

Study indicates that ketamine-induced changes in functional connectivity last for several days after administration of the substanceKernel Flow gathers real-time functional brain activity during clinical and research studies evaluating psychedelic-based therapeuticsTechnology is “precisely what we need to accelerate the development of psychedelics into therapeutics,” says Cybin CEO New data confirms Cybin’s (NEO: CYBN) (NYSE American: CYBN) focus on and commitment to progressing psychedelics to therapeutics. The company’s feasibility study using Kernel Flow confirms the device’s ability to successfully measure the neuro-effect of ketamine (https://ibn.fm/blLwT), based on study results presented at the PSYCH Symposium in London. Cybin has announced that preliminary data…

MondayJun 27, 2022 12:00 pm

Cepton, Inc. (NASDAQ: CPTN), a Leader in Lidar, Continues to Execute on its Core Strategic Milestones Across Automotive & Smart Infrastructure

Cepton develops lidar sensors for ADAS and autonomous driving, and has been awarded the largest lidar production contract to date with products set to debut next year across General Motor’s Ultra Cruise ADAS platformAward covers 4 target vehicle models in 2023, 4+ models in 2024, and an anticipated 4+ models in 2025 with Cadillac being the first to introduce the Ultra Cruise technologyCepton’s proprietary MMT(R) technology provides a highly competitive price for performance and reliabilityFounder-led, visionary management team with substantial “skin in the game” Since becoming public in early 2022, Cepton (NASDAQ: CPTN) has not deviated from its plan to…

MondayJun 27, 2022 11:15 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Grows Quarterly Net Income by Over 359% Yoy, Sees Margins Widen by Nearly 43%

Golden Matrix Group recently reported its 15th consecutive quarter of profitabilityGMGI’s second quarter revenues rose 221% YoY with net income expanding by upwards of 359% YoYGMGI attributed the rise in revenues to the added contribution from UK-based competition company, RKingsCompetitions Ltd, which Golden Matrix acquired in November 2021Management expressed their continued optimism on GMGI’s future prospects, with the company’s B2B and B2C verticals both showing robust growth Fifteen consecutive quarters of profitability is a remarkable feat; even Amazon, the world's largest e-commerce operator, reported a net loss over the past three months. Moreover, Golden Matrix Group (NASDAQ: GMGI), a developer…

MondayJun 27, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Reach of its Drug Delivery Technology Through Newly Inked Agreements with Beverage Developer BevNology

Drug delivery technology innovator Lexaria Bioscience has developed a patented technology showing superiority in animal and human testing as a means of improving existing drug brands’ performance and establishing new solutions for unmet medical needsThe company recently announced agreements with beverage developer BevNology to expand production capabilities for Lexaria's own growing list of B2B clientele and empowering BevNology to offer DehydraTECH products with active ingredients derived from hemp including CBD under BevNology and partnered brands The technology is called DehydraTECH — improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery Lexaria also recently announced an…

FridayJun 24, 2022 12:00 pm

Hope of Herd Immunity Dwindles Alongside Federal COVID-19 Budget and Supplies; Aditxt Inc. (NASDAQ: ADTX) and AditxtScore(TM) Could Create Map to COVID-19 Immune Responses

Two years after a vaccine was made available for COVID-19, fewer than 70% of Americans have been vaccinatedThe AditxtScore(TM) can provide the necessary answers to individualized immune response questions and direct on the best course of treatment for the individual – not the herdNo additional funding for COVID-19 relief has been approved by Congress, requiring the Biden Administration to reallocate funds to prepare for the fall months and uptick in virus countsThe reallocation of funds for further vaccine development has reduced the amount spent on testing efforts causing concern for epidemiologists due to the lack of variant tracking The COVID-19…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Category: Tiny Gem